MT Newswires21d agobullish
Eli Lilly Wins Full FDA Approval for Selpercatinib in Solid TumorsEli Lilly and Company (LLY) on Tuesday received traditional approval from the US Food and Drug Admin
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Eli Lilly and Company (LLY) on Tuesday received traditional approval from the US Food and Drug Admin
Baxfendy gained FDA clearance for uncontrolled hypertension patients as AstraZeneca expands its cardiovascular and metabolic portfolio.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.